Compare LAB & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LAB | GBAB |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.5M | 396.7M |
| IPO Year | 2008 | 2010 |
| Metric | LAB | GBAB |
|---|---|---|
| Price | $0.89 | $14.15 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.35 | N/A |
| AVG Volume (30 Days) | ★ 5.0M | 84.0K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.54 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $101,937,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | $2.61 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.70 | $13.51 |
| 52 Week High | $1.72 | $15.94 |
| Indicator | LAB | GBAB |
|---|---|---|
| Relative Strength Index (RSI) | 51.51 | 42.94 |
| Support Level | $0.79 | $13.94 |
| Resistance Level | $1.01 | $14.23 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 71.61 | 18.18 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.